Detalhe da pesquisa
1.
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med
; 389(20): 1851-1861, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870969
2.
Novel prognostic nomogram for predicting recurrence-free survival in medullary thyroid carcinoma.
Histopathology
; 84(6): 947-959, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253940
3.
The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary Thyroid Cancer.
Endocr Pract
; 30(3): 218-224, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38103829
4.
A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma.
Mod Pathol
; 36(12): 100329, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716505
5.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Cancer
; 128(24): 4203-4212, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259380
6.
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Oncologist
; 24(6): e241-e250, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30918109
7.
Multiple endocrine neoplasia: an update.
Intern Med J
; 49(8): 954-961, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31387156
8.
Attractions and barriers to Australian physician-researcher careers.
Intern Med J
; 49(2): 171-181, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30152020
9.
Clinical guidance for radioiodine refractory differentiated thyroid cancer.
Clin Endocrinol (Oxf)
; 88(4): 529-537, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29095527
10.
Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma.
BMC Cancer
; 17(1): 497, 2017 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28738844
11.
TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas.
Clin Endocrinol (Oxf)
; 85(2): 283-90, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26667986
12.
Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.
Oncologist
; 20(3): 247-56, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25657202
13.
Hypoglycemia and risk of death in critically ill patients.
N Engl J Med
; 367(12): 1108-18, 2012 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22992074
14.
Improving Outcomes in Adrenocortical Cancer: An Australian Perspective.
Ann Surg Oncol
; 22(7): 2309-16, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25319576
15.
Pheochromocytomas in Multiple Endocrine Neoplasia Type 2.
Recent Results Cancer Res
; 204: 157-78, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26494388
16.
Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
Clin Endocrinol (Oxf)
; 80(1): 25-33, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24102379
17.
MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.
BMC Cancer
; 14: 200, 2014 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24641801
18.
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
Cancer
; 119(24): 4358-65, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24301304
19.
Medullary Thyroid Cancer: Updates and Challenges.
Endocr Rev
; 44(5): 934-946, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37204852
20.
Challenges and Strategies to Combat Resistance Mechanisms in Thyroid Cancer Therapeutics.
Thyroid
; 33(6): 682-690, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36924302